Bristol Myers SquibbX (Twitter)Oct 12, 2026

Bristol-Myers Squibb announced topline Phase 3 trial results for an investigational medicine for idiopathic pulmonary fibrosis.

Source

XOct 12, 2026

@bmsnews

likes: 24
replies: 0
reposts: 8
quotes: 1
views: 2,573
bookmarks: 1

Post

#MEDIA: Today, we announced topline results from a Phase 3 trial for an investigational medicine for adults living with idiopathic pulmonary fibrosis. Read more: https://t.co/4NxEPPNn6N https://t.co/2GQmZxhMAO

x.com/bmsnews/status/2109597711364153787Read the full source

Extracted by Autobound

From the Signal API record

Signal: X (Twitter)

Account: @bmsnews
Account location: New York, New York

More X (Twitter) signals at other companies

X (Twitter)AbbVieAbbVie presented new study findings on Crohn's Disease management at the ACG2026 conference.X (Twitter)Oct 14, 2026
X (Twitter)AnthropicThe user shared their Wordle score of 3/6 for game 1,942.X (Twitter)Oct 14, 2026
X (Twitter)BCGBCG's 2026 Applied AI Index identifies three core elements for companies engineering AI value.X (Twitter)Oct 14, 2026

The full record

From the Signal API record

Details

Handle: Bmsnews
Verified account: No
Followers: 150,902

Topics and mentions

Extraction

Detected: Oct 12, 2026
signal_type: twitter-company-posts
signal_subtype: twitter_post

Use this data

Get every X (Twitter) signal for Bristol Myers Squibb and the companies you sell to, in the tools you already use.

Ask Claude about it
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Bristol Myers Squibb this week?”
MCP setup guide
Send it to your own tools
The Signal API returns X (Twitter) signals for any list of companies as JSON, for your CRM, warehouse or app.
Signal API
Try it free
Sign up and spend your free credits on the companies you sell to.
Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full twitter-company-posts record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

linkedin_urlValue in the API
industriesValue in the API
employee_count_lowValue in the API
employee_count_highValue in the API
revenueValue in the API
descriptionValue in the API

Signal

signal_nameValue in the API
associationValue in the API

Start Free1,000 free creditsUse it in Claude via MCP

Show the full JSONThe record on this page and the API request

GET /v1/signals/0867cba7-20aa-4130-a0c7-3953debd2a3d returns this record as JSON. POST /v1/companies/enrich returns every signal for bms.com.

{
  "signal_id": "0867cba7-20aa-4130-a0c7-3953debd2a3d",
  "signal_type": "twitter-company-posts",
  "signal_subtype": "twitter_post",
  "detected_at": "2026-10-12T10:51:03+00:00",
  "company": {
    "name": "Bristol Myers Squibb",
    "domain": "bms.com"
  },
  "data": {
    "tags": [
      "Pharmaceuticals",
      "Medical Research",
      "Clinical Operations"
    ],
    "urls": [
      "https://bit.ly/4ycc8RL"
    ],
    "summary": "Bristol-Myers Squibb announced topline Phase 3 trial results for an investigational medicine for idiopathic pulmonary fibrosis.",
    "hashtags": [
      "MEDIA"
    ],
    "is_reply": false,
    "language": "en",
    "post_url": "https://x.com/bmsnews/status/2109597711364153787",
    "tweet_id": "2109597711364153787",
    "num_likes": 24,
    "num_views": 2573,
    "post_text": "#MEDIA: Today, we announced topline results from a Phase 3 trial for an investigational medicine for adults living with idiopathic pulmonary fibrosis. Read more: https://t.co/4NxEPPNn6N https://t.co/2GQmZxhMAO",
    "num_quotes": 1,
    "initiatives": [
      {
        "topic": "Phase 3 trial results announcement for idiopathic pulmonary fibrosis medicine",
        "urgency": 0.8
      }
    ],
    "num_replies": 0,
    "num_reposts": 8,
    "posted_date": "Mon Oct 12 10:51:03 +0000 2026",
    "num_bookmarks": 1,
    "company_twitter_bio": "We work every day to transform patients’ lives through science. See our community guidelines: https://t.co/Qd22DZ1dFw",
    "company_twitter_url": "https://x.com/bmsnews",
    "company_twitter_handle": "bmsnews",
    "company_twitter_location": "New York, New York",
    "company_twitter_verified": false,
    "company_twitter_followers": 150902,
    "company_twitter_following": 1025,
    "company_twitter_total_tweets": 8977,
    "company_twitter_account_created": "Tue Apr 21 19:31:42 +0000 2009",
    "company_twitter_verification_type": "Business"
  }
}

curl https://signals.autobound.ai/v1/signals/0867cba7-20aa-4130-a0c7-3953debd2a3d \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"bms.com","limit":20}'

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.